# Dyne Therapeutics, Inc. (DYN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Dyne Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/DYN/mda/fy2025/): filed 2026-03-02; accession 0001193125-26-084178 (https://www.sec.gov/Archives/edgar/data/1818794/000119312526084178/dyn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/DYN/mda/fy2024/): filed 2025-02-27; accession 0000950170-25-028356 (https://www.sec.gov/Archives/edgar/data/1818794/000095017025028356/dyn-20241231.htm)
- [FY 2023 MD&A](/company/DYN/mda/fy2023/): filed 2024-03-05; accession 0000950170-24-025402 (https://www.sec.gov/Archives/edgar/data/1818794/000095017024025402/dyn-20231231.htm)
- [FY 2022 MD&A](/company/DYN/mda/fy2022/): filed 2023-03-02; accession 0000950170-23-005708 (https://www.sec.gov/Archives/edgar/data/1818794/000095017023005708/dyn-20221231.htm)
- [FY 2021 MD&A](/company/DYN/mda/fy2021/): filed 2022-03-10; accession 0000950170-22-003290 (https://www.sec.gov/Archives/edgar/data/1818794/000095017022003290/dyn-20211231.htm)

Back to /company/DYN/